ArticleJournal of ovarian research2025

Research on the process and molecular mechanism of inhibiting serous ovarian cancer by PRTN3 and its inhibitor Sivelestat.

Changtao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.